DIS3 gene mutations occur in approximately 10% of patients with multiple myeloma (MM); furthermore, DIS3 expression can be affected by monosomy 13 and del(13q), found in roughly 40% of MM cases. Despite the high incidence of DIS3 mutations and deletions, the biological significance of DIS3 and its contribution to MM pathogenesis remains poorly understood. Herein, we investigated the functional role of DIS3 in MM, by exploiting a loss of function approach in human MM cell lines. We found that DIS3 knockdown inhibits proliferation in MM cell lines and largely affects MM plasma cells (PC) cell cycle progression, finally inducing a significant increase of the percentage of cells in the G0/G1 phase and a decrease in the S and G2/M phases. DIS3 plays an important role not only in the control of MM PCs cell cycle, but also in the centrosome duplication cycle, which are strictly coregulated in physiological condition in the G1 phase. Indeed, DIS3 silencing leads to the formation of supernumerary centrosomes accompanied by the assembing of multipolar spindles during mitosis. In MM, centrosome amplification is present in about a third of patients and may represent a mechanism leading to genomic instability. These findings strongly prompt further studies investigating the relevance of DIS3 in the centrosome duplication process; indeed, a combination of DIS3 defects and deficient spindle-assembly checkpoint, can allow cells to progress through the cell cycle without proper chromosome segregation generating aneuploid cells which finally lead to the development of MM.

DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification / V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, G. Fabbiano, V. Traini, K. Todoerti, S. Erratico, A. Ciarrocchi, V. Fragliasso, D. Giannandrea, F. Tumiatti, R. Chiaramonte, Y. Torrente, P. Finelli, E. Morelli, N.C. Munshi, N. Bolli, A. Neri, E. Taìana. - In: HAEMATOLOGICA. - ISSN 1592-8721. - (2023). [Epub ahead of print] [10.3324/haematol.2023.283274]

DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification

V.K. Favasuli;D. Ronchetti
Secondo
;
I. Silvestris;V. Traini;K. Todoerti;S. Erratico;D. Giannandrea;F. Tumiatti;R. Chiaramonte;Y. Torrente;P. Finelli;N. Bolli;A. Neri
Penultimo
;
2023

Abstract

DIS3 gene mutations occur in approximately 10% of patients with multiple myeloma (MM); furthermore, DIS3 expression can be affected by monosomy 13 and del(13q), found in roughly 40% of MM cases. Despite the high incidence of DIS3 mutations and deletions, the biological significance of DIS3 and its contribution to MM pathogenesis remains poorly understood. Herein, we investigated the functional role of DIS3 in MM, by exploiting a loss of function approach in human MM cell lines. We found that DIS3 knockdown inhibits proliferation in MM cell lines and largely affects MM plasma cells (PC) cell cycle progression, finally inducing a significant increase of the percentage of cells in the G0/G1 phase and a decrease in the S and G2/M phases. DIS3 plays an important role not only in the control of MM PCs cell cycle, but also in the centrosome duplication cycle, which are strictly coregulated in physiological condition in the G1 phase. Indeed, DIS3 silencing leads to the formation of supernumerary centrosomes accompanied by the assembing of multipolar spindles during mitosis. In MM, centrosome amplification is present in about a third of patients and may represent a mechanism leading to genomic instability. These findings strongly prompt further studies investigating the relevance of DIS3 in the centrosome duplication process; indeed, a combination of DIS3 defects and deficient spindle-assembly checkpoint, can allow cells to progress through the cell cycle without proper chromosome segregation generating aneuploid cells which finally lead to the development of MM.
DIS3; Multiple Myeloma; cell cycle; centrosome amplification
Settore MED/15 - Malattie del Sangue
   Dissecting the role and druggability of NEAT1 and discovery of novel deregulated long noncoding RNAs in multiple myeloma (1° anno)
   FONDAZIONE AIRC PER LA RICERCA SUL CANCRO ETS
   IG 2020 ID 24365

   spontaneous Evolution and Clonal heterOgeneity in MoNoclonal Gammopathies: from mechanisms of progression to clinical management (bECOMiNG)
   bECOMiNG
   EUROPEAN COMMISSION
   H2020
   817997
2023
13-lug-2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
11158-Article Text-81535-1-10-20230713_compressed.pdf

accesso aperto

Descrizione: Article
Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 2.55 MB
Formato Adobe PDF
2.55 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/990008
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact